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BACKGROUND: Postoperative pain is a major barrier in recovery of patients 
undergoing laparoscopic surgeries, mostly in the first 24 hrs. There are conflicting 
results with regard to lidocaine dose, duration and efficacy as analgesic even though it 
is part of ERAS protocol. We aim to compare intravenous lidocaine infusion with 
TEA to determine the most efficient, cost-effective , safe, non opioid mode of 
analgesia for laparoscopic surgeries. 
OBJECTIVES: To compare the effectiveness of intravenous Lidocaine infusion and 
Thoracic Epidural Analgesia (TEA) in attenuating acute postoperative pain, length of 
hospital stay and Quality of Recovery (QoR15) score. 
METHODS: After clearance from IRB, 35 patients >18 years undergoing 
Laparoscopic Anterior Resection, Low Anterior Resection, Ultra – Low Anterior 
resection and Sigmoid Colectomy were enrolled in this prospective, randomized 
control study. They were assessed for baseline recovery parameters using QoR15 
score preoperatively and were randomized into two groups. Group A (n=19)  received 
intravenous Lidocaine (2mg/kg bolus and 2mg/kg/hr infusion till 30 minutes after 
surgery). Group B (n=16) patients had TEA before induction (in T8-9/T9-10 space, a 
bolus of  0.25% Bupivacaine followed by an infusion) for the next 48 hrs. 
Intraoperative total opioid dose noted. Post operative pain using NRS was recorded at 
2, 4, 8, 12 and 24hrs. Recovery parameters were recorded using QoR - 15 score 
between 24 - 48 hrs. All patients received rescue analgesia through PCA for 24 hrs. 
STATISTICAL ANALYSIS: Descriptive statistics was reported using Mean+/-SD 
for continuous variables. Categorical variables was reported using frequency and 
percentage. Comparison of means between the two arms for continuous variables was 
done using Two independent sample t test. Association between the arms with respect 
to the categorical variable was reported using Chi-square/Fisher's exact test. 
RESULTS: There was no difference in pain scores measured at 5, 30, 60, 90 minutes 
and 2 hours after arrival to PACU (p < 0.05). The NRS in lidocaine group was 
significantly higher than TEA group from 4
th
 hour onwards. 24 hr analgesic 
consumption in Lidocaine group was double that used in TEA at all time points. The 
duration of hospital stay was comparable in both groups (p – 0.687). However post 
operative QoR - 15 score was better in Group B (Group A - 124.9 ± 21.7, Group B - 
121.2 ± 20.1, p – 0.601), though it was not statistically significant. 
CONCLUSIONS: TEA is superior to lidocaine as it has better pain relief, lower  
intensity of postoperative pain in the first 24 hours. However, both lidocaine and TEA 
have comparable effects on the overall quality of recovery and duration of hospital 
stay, without any adverse effects. Thus the use of iv lidocaine as an inexpensive safe 
modality which can potentially be used as an alternative mode of perioperative, opioid 
sparing analgesia cannot be ruled out. 
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